TUCSON, Sept. 13 /PRNewswire/ -- The Critical Path Institute (C-Path) has received $675,000 from the US Food and Drug Administration (FDA) for the first year of what is anticipated to be a multi-year, multi phased research program in cardiovascular disease. Additional support for subsequent year awards will depend upon successful completion of the first year and additional Federal support, but could result in up to $2 million over three years to support a collaborative scientific and educational program with the University of Utah and Intermountain Health Care, both based in Salt Lake City.
